Mingyue Wu

790 total citations · 1 hit paper
25 papers, 577 citations indexed

About

Mingyue Wu is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mingyue Wu has authored 25 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mingyue Wu's work include Metabolism, Diabetes, and Cancer (4 papers), Diabetes Treatment and Management (3 papers) and Sodium Intake and Health (2 papers). Mingyue Wu is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Diabetes Treatment and Management (3 papers) and Sodium Intake and Health (2 papers). Mingyue Wu collaborates with scholars based in China and Czechia. Mingyue Wu's co-authors include Yihai Liu, Lina Kang, Biao Xu, Lina Kang, Biao Xu, Jiamin Xu, Chunbo Tang, Ning Chen, Yifei Du and Hua Yuan and has published in prestigious journals such as Chemical Engineering Journal, Chemosphere and Frontiers in Immunology.

In The Last Decade

Mingyue Wu

24 papers receiving 574 citations

Hit Papers

Association between compo... 2023 2026 2024 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyue Wu China 15 155 139 137 90 87 25 577
Songbo Fu China 14 303 2.0× 90 0.6× 203 1.5× 82 0.9× 91 1.0× 55 791
Lingyu Fu China 15 120 0.8× 115 0.8× 86 0.6× 55 0.6× 54 0.6× 55 765
Ahmed A. Hasan Germany 20 219 1.4× 62 0.4× 216 1.6× 91 1.0× 137 1.6× 39 779
Jung A Kim South Korea 17 138 0.9× 92 0.7× 208 1.5× 64 0.7× 107 1.2× 49 722
Mi Hae Seo South Korea 14 117 0.8× 140 1.0× 164 1.2× 38 0.4× 112 1.3× 31 636
Yiting Xu China 17 221 1.4× 123 0.9× 246 1.8× 104 1.2× 68 0.8× 69 752
B. I. Freedman United States 14 227 1.5× 129 0.9× 222 1.6× 74 0.8× 86 1.0× 19 1.1k
Sho Kinguchi Japan 15 113 0.7× 155 1.1× 146 1.1× 34 0.4× 88 1.0× 51 538
Nicolai Worm Germany 7 145 0.9× 147 1.1× 123 0.9× 30 0.3× 78 0.9× 20 554

Countries citing papers authored by Mingyue Wu

Since Specialization
Citations

This map shows the geographic impact of Mingyue Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyue Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyue Wu more than expected).

Fields of papers citing papers by Mingyue Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyue Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyue Wu. The network helps show where Mingyue Wu may publish in the future.

Co-authorship network of co-authors of Mingyue Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyue Wu. A scholar is included among the top collaborators of Mingyue Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyue Wu. Mingyue Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yihai, Sen Yan, Mingyue Wu, et al.. (2025). Subaxillary implantation of mesenchymal stem cell spheroids is a novel therapy for myocardial ischemia reperfusion injury. Chemical Engineering Journal. 508. 160906–160906.
2.
Wu, Mingyue, et al.. (2023). Association between composite dietary antioxidant index and hypertension: insights from NHANES. Clinical and Experimental Hypertension. 45(1). 2233712–2233712. 99 indexed citations breakdown →
3.
Wu, Mingyue, et al.. (2023). Association of low-density lipoprotein-cholesterol with all-cause and cause-specific mortality. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(6). 102784–102784. 7 indexed citations
4.
Liu, Yihai, Lei Chang, Mingyue Wu, Biao Xu, & Lina Kang. (2022). Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery Disease. Angiology. 73(7). 655–659. 14 indexed citations
5.
Liu, Yihai, Mingyue Wu, Jiamin Xu, Biao Xu, & Lina Kang. (2021). Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice. European Journal of Pharmaceutical Sciences. 161. 105788–105788. 37 indexed citations
6.
Ni, Jie, et al.. (2021). Correction: Psychological Impact of the COVID-19 Pandemic on Chinese Health Care Workers: Cross-Sectional Survey Study. JMIR Mental Health. 8(2). e27596–e27596. 8 indexed citations
7.
Liu, Yihai, Mingyue Wu, Biao Xu, & Lina Kang. (2021). Association between the urinary nickel and the diastolic blood pressure in general population. Chemosphere. 286(Pt 3). 131900–131900. 18 indexed citations
8.
Wu, Mingyue, et al.. (2021). Osteoporosis was associated with severe abdominal aortic calcification based on a cross-sectional study. Archives of Osteoporosis. 16(1). 79–79. 11 indexed citations
9.
Liu, Yihai, Jiamin Xu, Mingyue Wu, Biao Xu, & Lina Kang. (2021). Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity. Lipids in Health and Disease. 20(1). 5–5. 38 indexed citations
10.
Liu, Yihai, Mingyue Wu, Biao Xu, & Lina Kang. (2021). Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model. Journal of Inflammation Research. Volume 14. 2277–2287. 30 indexed citations
11.
Wang, Long, Beibei Gao, Mingyue Wu, et al.. (2021). Profiles of Immune Cell Infiltration in Carotid Artery Atherosclerosis Based on Gene Expression Data. Frontiers in Immunology. 12. 599512–599512. 15 indexed citations
12.
Liu, Yihai, Mingyue Wu, Jiamin Xu, et al.. (2020). Association between Triglyceride and glycose (TyG) index and subclinical myocardial injury. Nutrition Metabolism and Cardiovascular Diseases. 30(11). 2072–2076. 35 indexed citations
13.
Ni, Jie, Yihai Liu, Kun Wang, et al.. (2020). Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway. Molecular Therapy — Nucleic Acids. 22. 948–956. 22 indexed citations
14.
Ni, Jie, et al.. (2020). Psychological Impact of the COVID-19 Pandemic on Chinese Health Care Workers: Cross-Sectional Survey Study. JMIR Mental Health. 8(1). e23125–e23125. 9 indexed citations
15.
Wu, Mingyue, et al.. (2017). Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis. BMC Ophthalmology. 17(1). 48–48. 24 indexed citations
16.
Shen, Ming, Yuanyuan Hu, Yukun Hu, et al.. (2013). Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk. Tumor Biology. 35(4). 3891–3897. 6 indexed citations
17.
Niu, Yu‐Ming, Ming Shen, Hui Li, et al.. (2012). No Association Between MTHFR A1298C Gene Polymorphism and Head and Neck Cancer Risk: A Meta-analysis Based on 9,952 Subjects. Asian Pacific Journal of Cancer Prevention. 13(8). 3943–3947. 7 indexed citations
18.
Niu, Yu‐Ming, Yuanyuan Hu, Mingyue Wu, et al.. (2011). CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis. Molecular Biology Reports. 39(1). 607–612. 16 indexed citations
19.
Tang, Chunbo, Ning Chen, Mingyue Wu, Hua Yuan, & Yifei Du. (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Research and Treatment. 117(2). 391–399. 78 indexed citations
20.
Wang, Hu, et al.. (2005). [Association of estrogen receptor gene polymorphisms and primary trigeminal neuralgia].. PubMed. 23(6). 495–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026